-
Mashup Score: 59Investigational mRNA Vaccine Induced Persistent Immune Response in - 1 month(s) ago
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Source: www.mskcc.orgCategories: General Medicine News, Onc News and JournalsTweet
Research presented by @TheVinodLab at #AACR24 shows that an investigational approach to treating #pancreaticcancer w/an #mRNA-based vaccine activates immune cells that can persist in the body for up to three years after treatment in certain patients. https://t.co/Ju5ftYSYa1